Skip to main content

Month: March 2026

Bowman Secures $3 Million+ Contracts for Critical Minerals Project in Nevada

Pathfinder-Tonopah Project backed by $896 Million U.S. EXIM LOI RESTON, Va., March 11, 2026 (GLOBE NEWSWIRE) — Bowman Consulting Group Ltd. (NASDAQ: BWMN), a national engineering services and program management firm, has been awarded over $3 million in new contracts by Pathfinder Development Corp. (“Pathfinder”) to lead feasibility analysis, engineering and support on site environmental remediation for the Pathfinder-Tonopah critical minerals project in Nevada. Supported by an $896 million letter of intent from the Export-Import Bank of the United States, the brownfield project will redevelop historic copper, molybdenum and silver resources into a modern integrated operation that advances U.S. energy and defense supply chains. The awards build on prior engineering support Bowman has provided Pathfinder over the past year. The scope...

Continue reading

Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates

Platform Rebrand of Researgency.ai; First Purpose-Built AI Agent for Biotech Expected to Ship Within Two Weeks ARLINGTON, Mass., March 11, 2026 (GLOBE NEWSWIRE) — KALA BIO, Inc. (NASDAQ: KALA) announces that it is ready to ship its first commercial AI product in approximately 14 days, transforming the Company from a clinical-stage biotech into a dual-engine growth story powered by both a proprietary drug pipeline and a scalable AI platform targeting the $180+ billion AI-in-healthcare market. Kala is building the Palantir for biotech, just as Palantir built a $250+ billion company by helping governments and enterprises make sense of massive data, Kala is doing the same for the biotech and pharmaceutical industry through its Researgency.ai platform, deploying purpose-built AI agents that handle the repetitive, high-stakes jobs that...

Continue reading

BranchOut Food Announces Partnership with Zesty Snackz and Top YouTube Creators to Launch Single-Ingredient Fruit Chips

Zesty Snackz collaboration taps millions of engaged followers to drive innovation in premium, single-ingredient snacks BEND, Ore., March 11, 2026 (GLOBE NEWSWIRE) — BranchOut Food Inc. (NASDAQ: BOF), a food technology company pioneering the next generation of natural fruit and vegetable snacks through its proprietary GentleDry™ process, today announced a partnership with Zesty Snackz and its founders, digital creators Brenten Szekely and Paul Cuffaro, to launch a new line of single-ingredient Fruit Chips under the Zest Snackz label. The collaboration brings together BranchOut’s proprietary GentleDry™ dehydration technology with Zesty Snackz’s fast-growing snack platform and the expansive digital reach of two of YouTube’s most recognizable lifestyle creators. Collectively, Brenten and Paul reach millions of viewers...

Continue reading

Bank of Åland plc: Directed share issue for implementation of the variable compensation system for members of the Executive Team and key individuals

Bank of Åland PlcStock Exchange Release – Total number of voting rights and capital11 March 2026, 12.30 EET Bank of Åland plc: Directed share issue for implementation of the variable compensation system for members of the Executive Team and key individuals On 11 March 2026, the Board of Directors of the Bank of Åland Plc (Ålandsbanken Abp) decided on a directed issue of new shares. These shares are being issued in accordance with the authorization granted by the Annual General Meeting on 26 March 2024.  In order to fulfil the Bank of Åland’s obligations within the framework of its variable compensation system targeted at members of the Executive Team and key individuals, the Board has decided to carry out a directed issue of 14,830 new Series B shares. The subscription price is EUR 49.49 per share, which is the weighted average of...

Continue reading

Validation of Patient-Reported Outcomes in the On-Demand Treatment of Hereditary Angioedema Attacks Published in Clinical Reviews in Allergy & Immunology

Data include a concurrent assessment of results collected from PGI and AMRA instruments, insights into clinically meaningful changes in HAE attack symptoms, and support for hierarchical ranking of RAPIDe-3 endpointsZUG, Switzerland, March 11, 2026 (GLOBE NEWSWIRE) — Pharvaris (Nasdaq: PHVS), a late-stage biopharmaceutical company developing novel, oral bradykinin B2 receptor antagonists to help address unmet needs of those living with bradykinin-mediated diseases such as hereditary angioedema (HAE) and acquired angioedema due to C1 inhibitor deficiency (AAE-C1INH), today announced that results from a Pharvaris-sponsored non-interventional, mixed methods, real-world study assessing the patient experience during acute HAE attacks across alternative endpoints used in clinical studies have been published in Clinical Reviews in Allergy...

Continue reading

AH Realty Trust Executes 4,000-Square-Foot Lease at Southern Post With Atlanta Golf & Social

The addition reflects continued demand for lifestyle-driven concepts within the Roswell, Georgia mixed-use community. VIRGINIA BEACH, Va., March 11, 2026 (GLOBE NEWSWIRE) — AH Realty Trust (NYSE: AHRT), previously Armada Hoffler, announced the execution of a new retail lease with Atlanta Golf & Social at Southern Post, the company’s premier mixed-use destination in Roswell, Georgia. The contemporary indoor golf and social concept will occupy approximately 4,000 square feet of first-generation retail space, further strengthening Southern Post’s diverse collection of retail, dining, wellness, and lifestyle offerings. Atlanta Golf & Social reflects growing demand for experience-driven retail concepts centered on social programming and shared activity that encourage repeat visitation within mixed-use destinations. The Southern...

Continue reading

Titan Mining to Start Shipping First Graphite Product and Feasibility Study Underway for 40,000 tpa Integrated Kilbourne Graphite Project

Project Designed to Supply ~50% of U.S. Natural Graphite Demand, Directly Addressing America’s 100% Import Reliance GOUVERNEUR, N.Y., March 11, 2026 (GLOBE NEWSWIRE) — Titan Mining Corporation (NYSE-A:TII, TSX:TI), (“Titan” or the “Company”) an existing zinc concentrate producer in upstate New York and the only end to end producer of natural flake graphite in the U.S., today announced the commencement of shipping of graphite concentrate from its demonstration facility and formal launch of its fully-funded Feasibility Study (“FS”) for its planned 40,000 tonne per annum Kilbourne Graphite Project in New York. The graphite demonstration plant at ESM has produced ~1,600 kgs of graphite concentrate and continues to ramp up to its nameplate capacity. Customer qualification shipments are underway. Titan is the only end to end producer...

Continue reading

Generac Announces Webcast of Upcoming 2026 Investor Day

WAUKESHA, Wis., March 11, 2026 (GLOBE NEWSWIRE) — Generac Holdings Inc. (“Generac”) (NYSE: GNRC), a leading global designer and manufacturer of energy technology solutions and other power products, today announced that it will be providing a webcast of its upcoming 2026 Investor Day presentation. Generac will be holding the Investor Day on Wednesday, March 25, 2026, where Aaron Jagdfeld, President and CEO, and other members of the Company’s management team will discuss key strategic priorities and growth opportunities. The Company will webcast its Investor Day presentation beginning at 8:30 a.m. EDT that day and expects to conclude at approximately 1:00 p.m. EDT. A link to the live webcast will be available prior to the scheduled presentation time on Generac’s website (http://www.generac.com), under the Investor...

Continue reading

Voyager Acquisition Corporation Announces Redemption Results in Connection with its Business Combination with VERAXA Biotech AG

BROOKLYN, N.Y., March 11, 2026 (GLOBE NEWSWIRE) — Voyager Acquisition Corporation (NASDAQ: “VACHU,” “VACH,” “VACHW”) (“Voyager” or the “Company”) today announced that holders of 25,217,315 of the Company’s Class A ordinary shares (“Class A shares”) exercised their right to redeem their shares for a pro rata portion of the funds in the Company’s trust account, reflecting redemptions of approximately 99.67% of the total Class A shares outstanding in connection with the completion of the Company’s business combination (the “Business Combination”) pursuant to the business combination agreement between the Company, VERAXA Biotech AG (“VERAXA”) and the other parties thereto (the “Business Combination Agreement”). The 25,217,315 Class A shares which were submitted for redemption have not been withdrawn and will accordingly...

Continue reading

Katapult Reports Fourth Quarter and Full Year 2025 Results

Delivers 13th Consecutive Quarter of Gross Originations Growth Pending Merger Transaction with The Aaron’s Company and CCF Holdings LLC Expected to Create a Premier Omnichannel Platform for Nonprime Consumers   PLANO, Texas, March 11, 2026 (GLOBE NEWSWIRE) — Katapult Holdings, Inc. (“Katapult” or the “Company”) (NASDAQ: KPLT), an e-commerce-focused financial technology company, today reported its financial results for the fourth quarter ended December 31, 2025. “We made a lot of operating and financial progress during 2025 driven both by the strength of our product offering as well as our team’s dedication to growth and success,” said Orlando Zayas, CEO of Katapult. “During 2025 we achieved 17% gross originations growth, which was supported by a 45% increase in applications and a 25% increase in lease originations, illustrating...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.